Identifying Molecular Drivers of Cancer
Completed
Conditions studied: Cancer, Tumor, Advanced Cancer
In brief
The primary aim of this study is to identify drivers of cancer by performing comprehensive genetic, proteomic, and metabolomic characterization of patient samples as a basis for understanding the underlying cause of disease.
Key facts
- Study ID
- NCT02470715
- Run by
- Avera McKennan Hospital & University Health Center
- People needed
- 579
- Starts
- 2014-04-01
- Expected to finish
- 2018-05-22
- Last updated by the study team
- 2018-05-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnoses with cancer but healthy enough to undergo a biopsy procedure
- Between the ages of 18 and 100
You may not qualify if…
- Patients who are pregnant
Where it is running
- Avera Cancer Institute — Sioux Falls, South Dakota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.